Sequence-specific DNA minor groove binders. Design and synthesis of netropsin and distamycin analogues

Bioconjugate Chemistry

Volumn 9, Issue 5, 1998, Pages 513-538

  Bailly, Christian ^a   Chaires, Jonathan B ^b  

^a INSERM   (France)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISTAMYCIN; GROOVE BINDERS; MINOR GROOVES; NETROPSIN;

BINDERS;

EID: 0032170961     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980008m     Document Type: Review

References (300)

1. Waring, M. J. (1981) DNA modification and cancer. Annu. Rev. Biochem. 50, 159.
2. Hurley, L. H. (1989) DNA and associated targets for drug design. J. Med. Chem. 32, 2027.
3. Patel, D. J. (1982) Antibiotic-DNA interactions: intermolecular nuclear overhauser effects in the netropsin-d(CGC-GAATTCGCG) complex in solution. Proc. Natl. Acad Sci. U.S.A. 79, 6424.
4. BrCGCG. J. Mol. Biol. 183, 553.
5. Kopka, M. L., Yoon, C., Goodsell, D., Pjura, P., and Dickerson, R. E. (1985) The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl. Acad. Sci. U.S.A. 82, 1376.
6. 1H NMR studies on the interaction between distamycin A and a symmetrical DNA dodecamer. Biochemistry 25, 3296.
7. Coll, M., Frederick, C. A., Wang, A. H. J., and Rich, A. (1987) A bifurcated hydrogen bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin. Proc. Natl. Acad. Sci. U.S.A. 84, 8385.
8. Coll, M., Aymami, J., van der Marel, G. A., van Boom, J. H., Rich, A., and Wang, A. H.-J. (1989) Molecular structure of the netropsin-d(CGCGATATCGCG) complex: DNA conformation in an alternating AT segment. Biochemistry 28, 310.
9. Pelton, J. G., and Wemmer, D. E. (1989) Structural characterization of a 2:1 distamycin A·d(CGCAAATTGGC) complex by two-dimensional NMR. Proc. Natl. Acad. Sci. U.S.A. 86, 5723.
10. 2 determined by two-dimensional NMR. J. Am. Chem. Soc. 112, 1393.
11. 6G]AATTCGCG)-netropsin complex. Biochemistry 31, 11823.
12. Tabernero, L., Verdaguer, N., Coll, M., Fita, I., van der Marel, G. A., van Boom, J. H., Rich, A., and Aymami, J. (1993) Molecular structure of the A-tract DNA dodecamer d(CGCAAATTTGCG) complexed with the minor groove binding drug netropsin. Biochemistry 32, 8403.
13. Geierstanger B. H., Dwyer, T. J., Bathini, Y., Lown, J. W., and Wemmer, D. E. (1993) NMR characterization of a heterocomplex formed by distamycin and its analog 2-ImD with d(CGCAAGTTGGC):d(GCCAACTTGCG): Preference for the 1:1:1 2-ImD:Dst:DNA complex over the 2:1 2-ImD:DNA and the 2:1 Dst:DNA complexes. J. Am. Chem. Soc. 115, 4474.
14. Goodsell, D. S., Kopka, M. L., and Dickerson, R. E. (1995) Refinement of netropsin bound to DNA: Bias and feedback in electron density map interpretation. Biochemistry 34, 4983.
15. Chen, X., Ramakrishnan, B., Rao, S. T., and Sundaraligam, M. (1994) Binding of two distamycin A molecules in the minor groove of an alternating B-DNA duplex. Struct. Biol. 1, 169.
16. Chen, X., Ramakrishnan, B., and Sundaralingam, M. (1995) Crystal structures of B-form DNA-RNA chimers complexed with distamycin. Nat. Struct. Biol. 2, 733.
17. Chen, X., Ramakrishnan, B., and Sundaralingam, M. (1997) Crystal structures of the side-by-side binding of distamycin to AT-containing DNA octamers d(ICITACIC) and d(ICATATIC). J. Mol. Biol. 267, 1157.
18. Wemmer, D. E., Geierstanger, B. H., Fagan, P. A., Dwyer, T. J., Jacobsen, J. P., Pelton, J. G., Ball, G. E., Leheny, A. R., Chang, W.-H., Bathini, Y., Lown, J. W., Rentzeperis, D., Marky, L. A., Singh, S., and Kollma, P. (1994) Minor groove Recognition of DNA by distamycin and its analogs. In Structural Biology: The State of Art (R. H. Sarma and M. H. Sarma, Eds.) pp 301-323, Adenine Press, New York.
19. Neidle, S. N. (1997) Crystallographic insights into DNA minor groove recognition by drugs. Biopolymers 44, 105.
20. Van Dyke, M. W., Hertzberg, R. P., and Dervan, P. B. (1983) Map of distamycin, netropsin and actinomycin binding sites on heterogeneous DNA: DNA cleavage-inhibition patterns with methidiumpropyl-EDTA·Fe(II). Proc. Natl. Acad. Sci. U.S.A. 79, 5470.
21. Portugal, J., and Waring, M. J. (1987) Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study. Eur. J. Biochem. 167, 281.
22. Portugal, J., and Waring, M. J. (1987) Hydroxyl radical footprinting of the sequence-selective binding of netropsin and distamycin to DNA. FEBS Lett. 225, 195.
23. Ward, B., Rehfuss, R., and Dabrowiak, J. C. (1987) Quantitative footprinting analysis of the netropsin-DNA interaction. J. Biomol. Struct. Dyn. 4, 685.
24. Ward, B., Rehfuss, R., Goodisman, J., and Dabrowiak, J. C. (1988) Determination of netropsin-DNA binding constants from footprinting data. Biochemistry 27, 1198.
25. Abu-Daya, A., Brown, P. M., and Fox, K. R. (1995) DNA sequence preferences of several AT-selective minor groove binding ligands. Nucleic Acids Res. 23, 3385.
26. Singh, S. B., Wemmer, D. E., and Kollman, P. A. (1994) Relative binding affinities of distamycin and its analog to d-(CGCAAGTTGGC)·d(GCCAACTTGCG): Comparison of simulation results with experiment. Proc. Natl. Acad. Sci. U.S.A. 91, 7673.
27. Tabernero, L., Bella, J., and Aleman, C. (1996) Hydrogen bond geometry in DNA-minor groove binding drug complexes. Nucleic Acids Res. 24, 3458.
28. Rentzeperis, D., and Marky, L. A. (1995) Interaction of minor groove ligands to an AAATT/AATTT site: Correlation of thermodynamic characterization and solution structure. Biochemistry 34, 2937.
29. a. Bruzik, J. P., Auble, D. T., and DeHaseth, P. L. (1987) Specific activation of transcription initiation by the sequence specific DNA-binding agents distamycin A and netropsin. Biochemistry 26, 950.
30. b. Fesen, M., and Pommier, Y. (1989) Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA. J. Biol. Chem. 264, 11354.
31. Woynarowski, J. M., McHugh, M., Sigmund, R. D., and Beerman, T. A. (1989) Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4′,6-diamidino-2-phenylindole. Mol. Pharmacol. 35, 177.
32. Woynarowski, J. M., Sigmund, R. D., and Beerman, T. A. (1989) DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. Biochemistry 28, 3850.
33. McHugh, M. M., Woynarowski, J. M., Sigmund, R. D., and Beerman, T. A. (1989) Effect of minor groove binding drugs on mammalian topoisomerase I activity. Biochem. Pharmacol. 38, 2323.
34. Broggini, M., Ponti, M., Ottolenghi, S., D'Incalci, M., Mongelli, N., and Mantovani, R. (1989) Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res. 17, 1051.
35. Levy, A., Weisman-Shomer, P., and Fry, M. (1989) Distamycin paradoxically stimulates the copying of oligo(dA)·Poly(dT) by DNA polymerases. Biochemistry 28, 7262.
36. McHugh, M., Sigmund, R. D., and Beerman, T. A. (1990) Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei. Biochem. Pharmacol. 39, 707.
37. Gambari, R., Barbieri, R., Nastruzzi, C., Chiorboli, V., Feriotto, G., Natali, G. P., Giacomini, P., and Arcamone, F. (1991) Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα gene. Biochem. Pharmacol. 41, 497.
38. Dorn, A., Affolter, M., Muller, M., Gehring, W. J., and Leupin, W. (1992) Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J. 11, 279.
39. Ueno, A., Baek, K, Jeon, C., and Agarwal, K. (1992) Netropsin specifically enhances RNA polymerase II termination at terminator sites in vitro. Proc. Natl. Acad. Sci. U.S.A. 89, 3676.
40. Oakley, M. G., Mrksich, M., and Dervan, P. B. (1992) Evidence that a minor groove-binding peptide and a major groove-binding protein can simultaneously occupy a common binding site on DNA. Biochemistry 31, 10969.
41. Chai, S., and Alonso, J. C. (1996) Distamysin-induced inhibition of formation of a nucleoprotein complex between the terminase small subunit G1P and the nonencapsidated end (pacL site) of Bacillus subtilis bacteriophage SPP1. Nucleic Acids Res. 24, 282.
42. Wartell, R. M., Larson, J. E., and Wells, R. D. (1974) Netropsin. A specific probe for A-T regions of duplex deoxyribonucleic acid. J. Biol. Chem. 249, 6719.
43. Zimmer, C., and Wähnert, U. (1986) Non-intercalating DNA-binding ligands: specificity of the interaction and there use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. Mol. Biol. 47, 31.
44. Kopka, M. L., and Larsen, T. A. (1992) Netropsin and the lexitropsins. The search for sequence-specific minor-groove-binding ligands. In Nucleic Acid Targeted Drug Design (C. L. Propst and T. J. Perun, T. J., Eds.) pp 303-374, Dekker, New York.
45. Youngquist, R. S., and Dervan, P. B. (1985) Sequence specific recognition of B-DNA by oligo(N-methylpyrrole carboxamides). Proc. Natl. Acad. Sci. U.S.A. 82, 2565.
46. Dervan, P. B. (1986) Design of sequence-specific DNA-binding molecules. Science 232, 464.
47. Goodsell, D., and Dickerson, R. E. (1986) Isohelical analysis of groove-binding drugs. J. Med. Chem. 29, 727.
48. Khorlin, A. A., Krylov, A. S., Grokhovsky, S. L., Zhuze, A. L., Zasedatelev, A. S., Gursky, G. V., and Gottikh, B. P. (1980) A new type of AT-specific ligand constructed of two netropsin-like molecules. FEBS Lett. 118, 311.
49. Lown, J. W., Krowicki, K., Balzarini, J., Newman, R. A., and De Clercq, E. (1989) Novel linked antiviral and antitumor agents related to netropsin and distamycin: synthesis and biological evaluation. J. Med. Chem. 32, 2368.
50. Wang, W., and Lown, J. W. (1992) Anti-HIV-I activity of linked lexitropsins. J. Med. Chem. 35, 2890.
51. Burckhardt, G., Simon, H., Störl, K., Triebel, H., Walter, A., Lown, J. W., and Zimmer, Ch. (1997) DNA binding studies and influence on the activity of DNA topoisomerases of bis-netropsin: different effects of analogues containing cis and trans ethylene linkers. J. Biomol. Struct. Dyn. 15, 81.
52. Wang, Z., Zimmer, C., Lown, J. W., and Knippers, R. (1997) Effects of bifunctional netropsin-related minor groove-binding ligands on mammalian type I topoisomerase. Biochem. Pharmacol. 53, 309.
53. Kissinger, K. L., Dabrowiak, J. C., and Lown, J. W. (1990) Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis-netropsin analogues deduced from footprinting analysis. Chem. Res. Toxicol. 3, 162.
54. Rao, K. E., Zimmermann, J., and Lown, J. W. (1991) Sequence-selective DNA binding by linked bis-N-methylpyrrole dipeptides: an analysis by MPE footprinting and force field calculations. J. Org. Chem. 56, 786.
55. Singh, M. P., Plouvier, B., Hill, G. C., Gueck, J., Pon, R. T., and Lown, J. W. (1994) Isohelicity and strand selectivity in the minor groove binding of chiral (1R,2R)- and (1S,2S)-bis(netropsin)-1,2-cyclopropanedicarboxamide ligands to duplex DNA. J. Am. Chem. Soc. 116, 7006.
56. Filipowsky, M. E., Kopka, M. L., Brazil-Zison, M., Lown, J. W., and Dickerson, R. E. (1996) Linked lexitropsins and the in vitro inhibition of HIV-1 reverse transcriptase RNA-directed DNA polymerization: A novel induced-fit of 3,5-m-pyridyl bisdistamycin to enzyme-associated template-primer. Biochemistry 35, 15397.
57. Leinsoo, T. A., Nikolaev, V. A., Grokhovskii, S. L., Surovaya, A. M., Sidorova, N. Y., Streltsov, S. A., Zasedatelev, A. S., and Zhuze, A. L. (1989) Synthetic DNA-binding ligands containing reaction centers specific for AT and GC base pairs. Mol. Biol. 23, 1616.
58. Nikolaev, V. A., Grokhovsky, S. L., Surovaya, A. N., Leinsoo, T. A., Sidorova, N. Y., Zasedatelev, A. S., Zhuze, A. L., Strahan, G. A., Shafer, R. H., and Gursky, G. V. (1996) Design of sequence-specific DNA binding ligands that use a two-stranded peptide motif for DNA sequence recognition. J. Biomol. Struct. Dyn. 14, 31.
59. Zakrzewska, K., and Pullman, B. (1988) Theoretical study of the sequence selectivity of isolexins, isohelical DNA groove binding ligands. Proposal for GC minor groove specific compounds. J. Biomol. Struct. Dyn. 5, 1043.
60. Pullman, B. (1989) Molecular mechanisms of specificity in DNA-antitumor drug interactions. In Perspectives in Quantum Chemistry (J. Jortner and B. Pullman, Eds.) Kluwer Academic Publishers, Dordrecht.
61. Zakrzewska, K., Randrianarivelino, M., and Pullman, B. (1988) Drug recognition of DNA. Proposal for GC minor groove specific ligands: vinylexins. J. Biomol. Struct. Dyn. 6, 331.
62. Marchand, C., Bailly, C., McLean, M. J., Moroney, S. E., and Waring, M. J. (1992) The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA. Nucleic Acids Res. 20, 5601.
63. Bailly, C., Marchand, C., and Waring, M. J. (1993) New binding sites for antitumor antibiotics created by relocating the purine 2-amino group in DNA. J. Am. Chem. Soc. 115, 3784.
64. Waring, M. J., and Bailly, C. (1994) The purine 2-amino group as a critical recognition element for binding of small molecules to DNA. Gene 149, 69.
65. Bailly, C., and Waring, M. J. (1995) Transferring the purine 2-amino group from guanines to adenines in DNA changes the sequence-specific binding of antibiotic. Nucleic Acids Res. 23, 885.
66. Bailly, C., Payet, D., Travers, A. A., and Waring, M. J. (1996) PCR-based development of DNA substrates containing modified bases: an efficient system for investigating the role of the exocyclic groups in chemical and structural recognition by minor groove binding drugs and proteins. Proc. Natl. Acad. Sci. U.S.A. 93, 13623-13628.
67. Lown, J. W. (1988) Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Anti-Cancer Drug Des. 3, 25.
68. Lown, J. W. (1994) DNA recognition by lexitropsins, minor groove binding agents. J. Mol. Recogni. 7, 79.
69. Lown, J. W., Krowicki, K., Balzarini, J., and De Clercq, E. (1986) Structure-activity relationship of novel oligopeptide antiviral and antitumor agents related to netropsin and distamycin. J. Med. Chem. 29, 1210.
70. Lown, J. W., Krowicki, K., Bhat, U. G., Skorobogaty, A., Ward, B., and Dabrowiak, J. C. (1986) Molecular recognition between oligopeptides and nucleic acids: novel imidazole-containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity. Biochemistry 25, 7408.
71. Krowicki, K, and Lown, J. W. (1987) Synthesis of novel imidazole-containing DNA minor groove binding oligopeptides related to the antiviral antibiotic netropsin. J. Org. Chem. 52, 3493.
72. Kissinger, K. L., Krowicki, K., Dabrowiak, J. C., and Lown, J. W. (1987) Molecular recognition between oligopeptides and nucleic acids: monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding. Biochemistry 26, 5590.
73. 2. J. Biomol. Struct. Dyn. 5, 939.
74. 1H NMR. J. Biomol. Struct. Dyn. 5, 1059.
75. 1H NMR studies. Nucleic Acids Res. 16, 665.
76. 1H NMR studies. Biochemistry 27, 445.
77. Lee, M., Krowicki, K., Hartley, J. A., Pon, R. T., and Lown, J. W. (1988) Molecular recognition between oligopeptides and nucleic acids: influence of Van der Waals contacts in determining the 3′-terminus of DNA sequences read by monocationic lexitropsins. J. Am. Chem. Soc. 110, 3641.
78. Burckhardt, G., Luck, G., Zimmer, C., Störl, J., Krowicki, K., and Lown, J. W. (1989) Variation of DNA sequence specificity of DNA-oligopeptide binding ligands related to netropsin: imidazole-containing lexitropsins. Biochim. Biophys. Acta 1009, 11.
79. Lee, M., Rhodes, A. L., Wyatt, M. D., Forrow, S., and Hartley, J. A. (1993) GC base sequence recognition by oligo-(imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, proton nuclear magnetic resonance, and methidiumpropylethylenediamine-tetraacetate-iron(II) footprinting studies. Biochemistry 32, 4237.
80. Wyatt, M. D., Garbiras, B. J., Lee, M., Forrow, S. M., and Hartley, J. A. (1994) Synthesis and DNA binding properties of a series of N to C linked and imidazole containing analogues of distamycin. Bioorg. Med. Chem. Lett. 4, 801.
81. Rao, K. E., Bathini, Y., and Lown, J. W. (1990) Synthesis of novel thiazole containing DNA minor groove binding oligopeptides related to the antibiotic distamycin. J. Org. Chem. 55, 728.
82. Rao, K. E., Shea, R. G., Yadagiri, B., and Lown, J. W. (1990) Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance. Anti-Cancer Drug Des. 5, 3.
83. 1H NMR evidence for thiazole intercalation. J. Biomol. Struct. Dyn. 8, 99.
84. 1H NMR and molecular modeling study. J. Biomol. Struct. Dyn. 9 (1).
85. Plouvier, B., Bailly, C., Houssin, R., Rao, K. E., Lown, J. W., Hénichart, J.-P., and Waring, M. J. (1991) DNA-sequence specific recognition by a thiazole analogue of netropsin: a comparative footprinting study. Nucleic Acids Res. 19, 5821.
86. 1H NMR studies. J. Mol. Recognit. 2, 84.
87. Pullman, A., and Pullman, B. (1981) Molecular electrostatic potential of the nucleic acids. Q. Rev. Biophys. 14, 289.
88. Marky, L. A., and Breslauer, K. J. (1987) Origins of netropsin binding affinity and specificity: correlation of thermodynamic and structural data. Proc. Natl. Acad Sci. U.S.A. 84, 4359.
89. Singh, S. B., Wemmer, D. E., and Kollman, P. A. (1994) Relative binding affinities of distamycin and its analog to d(CGCAAGTTGGC)·d(GCCAACTTGCG): Comparison of simulation results with experiment. Proc. Natl. Acad. Sci. U.S.A. 91, 7673.
90. Goodsell, D. S., Leung Ng, H., Kopka, M. L., Lown, J. W., and Dickerson, R. E. (1995) Structure of a dicationic mono-imidazole lexitropsin bound to DNA. Biochemistry 34, 16654.
91. Zhang, Y., Chen, F.-X., Mehta, P., and Gold, B. (1993) Groove- and sequence-selective alkylation of DNA by sulfonate esters tethered to lexitropsins. Biochemistry 32, 7954.
92. Haq, I., Ladbury, J. E., Chowdhry, B. Z., Jenkins, T. C., and Chaires, J. B. (1997) Specific binding of Hoechst 33258 to the d(CGCAAATTTGCG)2 duplex: calorimetric and spectroscopic studies. J. Mol. Biol. 271, 244.
93. Wade, W. S., and Dervan, P. B. (1987) Alteration of the sequence specificity of distamycin on DNA by replacement of an N-methylpyrrole carboxamide with pyridine-2-carboxamide. J. Am. Chem. Soc. 109, 1574
94. Bielawski, K., Bartulewicz, D., Krajewska, D., and Rozanski, A. (1996) Synthetic analogues of netropsin and distamycin. III. Synthesis of a pyridine analogue of the antitumor antibiotics. Rocz. Akad. Bialymst. 41, 293-304.
95. Bailly, C., Colson, P., Houssier, C., Houssin, R., Mrani, D., Gosselin, G., Imbach, J. L., Waring, M. J., Lown, J. W., and Hénichart, J. P. (1992) Binding properties and DNA sequence-specific recognition of two bithiazole-linked netropsin hybrid molecules. Biochemistry 31, 8349.
96. Fagan, P., and Wemmer, D. E. (1992) Cooperative binding of distamycin-A to DNA in the 2:1 mode. J. Am. Chem. Soc. 114, 1080.
97. 1H NMR. J. Med. Chem. 38, 1140.
98. Wade, W. S., Mrksich, M., and Dervan, P. B. (1993) Binding affinities of synthetic peptides, pyridine-2-carboxamidone-tropsin and 1-methylimidazole-2-carboxamidonetropsin, that form 2:1 complexes in the minor groove of double-helical DNA. Biochemistry 32, 11385.
99. Geierstanger, B. H., Jacobsen, J. P., Mrksich, M., Dervan, P. B., and Wemmer, D. E. (1994) Structural and dynamic characterization of the hetrerodimeric and homodimeric complexes between distamycin and 1-methylimidazole-2-carboxamine-netropsin bound to the minor groove of DNA. Biochemistry 33, 3055.
100. Mrksich, M., Wade, W. S., Dwyer, T. J., Geierstanger, B. H., Wemmer, D. E., and Dervan, P. B. (1992) Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. Proc. Natl. Acad. Sci. U.S.A. 89, 7586.
101. Geierstanger, B. H., Mrksich, M., Dervan, P. B., and Wemmer, D. E. (1994) Design of a G·C-specific DNA minor groove-binding peptide. Science 266, 646.
102. Kopka, M. L., Goodsell, D. S., Han, G. W., Chiu, T. K., Lown, J. W., and Dickerson, R. E. (1997) Definign GC-specificity in the minor groove: side-by-side binding of diimidazole lexitropsin to CATGGCCATG. Structure 5, 1033.
103. 6. J. Am. Chem. Soc. 115, 9892.
104. Mrksich, M., and Dervan, P. B. (1994) Design of a covalent peptide heterodimer for sequence-specific recognition in the minor groove of double-helical DNA. J. Am. Chem. Soc. 116, 3663.
105. 3-6, in complex with 5′-TGACT-3′ sites by two-dimensional NMR. J. Am. Chem. Soc. 115, 9900.
106. Mrksich, M., and Dervan, P. B. (1994) Hairpin peptide motif. A new class of oligopeptides for sequence-speicific recognition in the minor groove of double-helical DNA. J. Am. Chem. Soc. 116, 7983.
107. Cho, J., Parks, M. E., and Dervan, P. B. (1995) Cyclic polyamides for recognition in the minor groove of DNA. Proc. Natl. Acad. Sci. U.S.A. 92, 10389.
108. Trauger, J. W., Baird, E. E., Mrksich, M., and Dervan, P. B. (1996) Extension of sequence-specific recognition in the minor groove of DNA by pyrrole-imidazole polyamide to 9-13 base pairs. J. Am. Chem. Soc. 118, 6160.
109. Al-Said, N. H., and Lown, J. W. (1994) Synthesis of novel cross-linked bis-lexitropsins. Tetrahedron Lett. 35, 7577.
110. Chen, Y.-H., and Lown, J. W. (1994) A new DNA minor groove binding motif: cross-linked lexitropsins. J. Am. Chem. Soc. 116, 6995.
111. Chen, Y.-H., Yang, Y., and Lown, J. W. (1996) Optimization of cross-linked lexitropsins. J. Biomol. Struct. Dyn. 14, 341.
112. Chen, Y.-H., Yang, Y., and Lown, J. W. (1996) Design of distamycin analogues to probe the physical origin of the antiparallel side by side oligopeptide binding motif in DNA minor groove recognition. Biochem. Biophys. Res. Commun. 220, 213.
113. Parks, M. E., Baird, E. E., and Dervan, P. B. (1996) Optimization of the hairpin polyamide design for recognition of the minor groove of DNA. J. Am. Chem. Soc. 118, 6147.
114. 2-3′ sequences in the minor groove of DNA by hairpin polyamides. J. Am. Chem. Soc. 118, 6153.
115. Kelly, J. J., Baird, E. E., and Dervan, P. B. (1996) Binding site size limit of the 2:1 pyrrole-imidazole polyamide-DNA motif. Proc. Natl. Acad. Sci. U.S.A. 93, 6981.
116. Pilch, D. S., Poklar, N., Gelfand, C. A., Law, S. M., Breslauer, K. J., Baird, E. E., and Dervan, P. B. (1996) Binding of a hairpin polyamide in the minor groove of DNA: sequence-specific enthalpic discrimination. Proc. Natl. Acad. Sci. U.S.A. 93, 8306.
117. White, S., Baird, E. E., and Dervan, P. B. (1996) Effects of the A·T/T·A degeneracy of pyrrole-imidazole polyamide recognition in the minor groove of DNA. Biochemistry 35, 12532.
118. Trauger, J. W., Baird, E. E., and Dervan, P. B. (1996) Extended hairpin polyamide motif for sequence-specific recognition in the minor groove of DNA. Chem. Biol. 3, 369.
119. Walker, W. L., Landaw, E. M., Dickerson, R. E., and Goodsell, D. S. (1997) Estimation of the DNA sequence discriminatory ability of hairpin-linked lexitropsins. Proc. Natl. Acad. Sci. U.S.A. 94, 5634.
120. Lamanie de Clairac, R. P., Geierstanger, B. H., Mrksich, M., Dervan, P. B., and Wemmer, D. E. (1997) NMR characterization of hairpin polyamide complexes with the minor groove of DNA. J. Am. Chem. Soc. 119, 7909.
121. White, S., Baird, E. E., and Dervan, P. B. (1997) Orientation preferences of pyrrole-imidazole polyamides in the minor groove of DNA. J. Am. Chem. Soc. 119, 6953.
122. White, S., Baird, E. E., and Dervan, P. B. (1997) On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides. Chem. Biol. 4, 569.
123. Geierstanger, B. H., Mrksich, M., Dervan, P. B., and Wemmer, D. E. (1996) Extending the recognition site of designed minor groove binding molecules. Nat. Struct. Biol. 3, 321.
124. Baird, E. E., and Dervan, P. B. (1997) Solid-phase synthesis of polyamides containing imidazole and pyrrole amino acids. J. Am. Chem. Soc. 118, 6141.
125. Swalley, S. E., Baird, E. E., and Dervan, P. B. (1997) Discrimination of 5′-GGGG-3′, 5′-GCGC-3′, and 5′-GGCC-3′ sequences in the minor groove of DNA by eight-ring hairpin polyamides. J. Am. Chem. Soc. 119, 8756.
126. 2-3′ sequence in the minor groove of DNA by a eight-ring hairpin polyamide. J. Am. Chem. Soc. 119, 8198-8206.
127. Turner, J. M., Baird, E. E., and Dervan, P. B. (1997) Recognition of seven base pair sequences in the minor groove of DNA by ten-ring pyrrole-imidazole polyamide hairpin. J. Am. Chem. Soc. 119, 7636.
128. Kielkopf, C. L., Baird, E. E., Dervan, P. B., and Rees, D. C. (1998) Structural basis for G·C recognition in the DNA minor groove. Nat. Struct. Biol. 5, 104.
129. White, S., Szewczyk, J. W., Turner, J. M., Baird, E. E., and Dervan, P. B. (1998) Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature 391, 468.
130. Herman, D. M., Baird, E. E., and Dervan, P. B. (1998) Stereochemical control of the DNA binding affinity, sequence specificity, and orientation preference of chiral hairpin polyamides in the minor groove. J. Am. Chem. Soc. 120, 1382.
131. Weisz, K. (1997) Polyamides as artificial regulators of gene expression. Angew. Chem., Int. Ed. Engl. 36, 2592.
132. Walker, W. L., Landaw, E. M., Dickerson, R. E., and Goodsell, D. S. (1997) Estimation of the DNA sequence discriminatory ability of hairpin-linked lexitropsins. Proc. Natl. Acad. Sci. U.S.A. 94, 5634.
133. Wemmer. D. (1998) Reading DNA. Nat. Struct. Biol. 5, 169.
134. Hélène, C. (1998) Reading the minor groove. Nature 391, 43.
135. Chaires, J. B. (1998) Drug-DNA interactions. Curr. Opin. Struct. Biol. (in press).
136. Trauger, J. W., Baird, E. E., and Dervan, P. B. (1996) Recognition of DNA by designed ligands at subnanomolar concentrations. Nature 382, 559.
137. Wemmer, D. E., and Dervan, P. B. (1997) Targeting the minor groove of DNA. Curr. Opin. Struct. Biol. 7, 355.
138. Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E., and Dervan, P. B. (1997) Regulation of gene expression by small molecules. Nature 387, 202.
139. Sinyakov, A. N., Lokhov, S. G., Kutyavin, I. V., Gamper, H. B., and Meyer, R. B., Jr. (1995) Exceptional and selective stabilization of A-T rich DNA-DNA duplexes by N-methylpyrrole carboxamide peptides conjugated to oligodeoxynucleotides. J. Am. Chem. Soc. 117, 4995.
140. Szewczyk, J. W., Baird, E. E., and Dervan, P. B. (1996) Cooperative triple-helix formation via a minor groove dimerization domain. J. Am. Chem. Soc. 118, 6778.
141. Szewczyk, J. W., Baird, E. E., and Dervan, P. B. (1996) Sequence-specific recognition of DNA by a major and minor groove binding ligand. Angew. Chem., Int. Ed. Engl. 35, 1487.
142. Alfieri, A., Animati, F., Arcamone, F., Bailly, C., Dentini, M., Felicetti, P., Iafrate, E., Lombardi, P., Manzini, S., Rossi, C., and Waring, M. J. (1997) Biological activity and DNA sequence specificity of synthetic carbamoyl analogues of distamycin. Antiviral Chem. Chemother. 8, 243.
143. Browne, K. A., He, G.-X., and Bruice, T. C. (1993) Microgonotropens and their interactions with DNA. 2. Quantitative evaluation of equilibrium constants for 1:1 and 2:1 binding of dien-microgonotropen-a, -b, and -c as well as distamycin and Hoechst 33258. J. Am. Chem. Soc. 115, 7072.
144. 1H NMR spectroscopy and molecular modeling. Proc. Natl. Acad. Sci. U.S.A. 90, 10018.
145. 2 and tren-microgonotropen-b by 2D NMR spectroscopy and restrained molecular modeling. J. Am. Chem. Soc. 116, 3726.
146. He, G.-X., Browne, K. A., Blaskò, A., and Bruice, T. C. (1994) Microgonotropens and their interactions with DNA. 4. Synthesis of the tripyrrole peptides tren-microgonotropen-a, -b, and -c and characterization of their interactions with dsDNA. J. Am. Chem. Soc. 116, 3716.
147. He, G.-X., Browne, K. A., Groppe, J. C., Blaskò, A., Mei, H.-Y., and Bruice, T. C. (1993) Microgonotropens and their interactions with DNA. 1. Synthesis of the tripyrrole peptides dien-microgonotropen-a, -b, and -c and characterization of their interactions with dsDNA. J. Am. Chem. Soc. 115, 7061.
148. 2: Tren-microgonotropen-b:Zn-(II) complex and solution studies of metal ion complexes of Tren-microgonotropen-b interacting with DNA. BioOrg. Med. Chem. 3, 631.
149. Xue, T., Browne, K. A., and Bruice, T. C. (1995) A novel minor groove binding reagent designed to serve as a "truck" to carry DNA modifying moieties into the major groove. Bioconjugate Chem. 6, 82.
150. Hansma, H. G., Browne, K. A., Groppe, J. C., Bezanilla, M., and Bruice, T. C. (1994) Bending and straightening of DNA induced by the same ligand: characterization with atomic force microscope. Biochemistry 33, 8436.
151. Bruice, T. C., Sengupta, D., Blaskò, A., Chiang, S.-Y., and Beerman, T. A. (1997) A microgonotropen branched cecaaza decabutylamine and its DNA and DNA/transcription factor interactions. BioOrg. Med. Chem. 5, 685.
152. Browne, K. A., and Bruice, T. C. (1992) Chemistry of phosphodiesters, DNA and models. 2. The hydrolysis of bis-(8-hydroxyquinoline) phosphate in the absence and presence of metal ions. J. Am. Chem. Soc. 114, 4951.
153. Bruice, T. C., Mei, H.-H., He, G.-X., and Lopez, V. (1992) Rational design of substituted trispyrrole peptides that complex with DNA by both selective minor-groove binding and electrostatic interaction with the phosphate backbone. Proc. Natl. Acad. Sci. U.S.A. 89, 1700.
154. Hartley, J. A. (1993) Selectivity in alkylating agent-DNA interactions. In Molecular Aspects of Anticancer Drug-DNA Interactions (S. Neidle and M. J. Waring, Eds.) Vol. 1, pp 1-31, Macmillan, London.
155. Hansen, M., and Hurley, L. (1996) Pluramycins. Old drugs having modern friends in structural biology. Acc Chem. Res. 29, 249.
156. Tomasz, M. (1994) The mitomycins: natural cross-linkers of DNA. In Molecular Aspects of Anticancer Drug-DNA Interactions (S. Neidle and M. J. Waring, Eds.) Vol. 2, pp 312-349, Macmillan, London.
157. 2 adduct by NMR and molecular modeling studies. Determination of the stereochemistry of the covalent linkage site, orientation in the minor groove of DNA and effect on local DNA structure. J. Am. Chem. Soc. 112, 3279.
158. Kopka, M. L., Goodsell, D., Baikalov, I., Grzeskowiak, K., Cascio, D., and Dickerson, R. E. (1994) Crystal structure of a covalent DNA-drug adduct: anthramycin bound to CCAACGTTGG and a molecular explanation of specificity. Biochemistry 33, 13593.
159. Hurley, L. H., and Draves, P. H. (1993) Molecular aspects of the interaction of (+)-CC-1065 with DNA. In Molecular Aspects of Anticancer Drug-DNA Interactions (S. Neidle and M. J. Waring, Eds.) Vol. 1, pp 89-133, Macmillan, London.
160. Hurley, L. H., and Sun, D. (1994) (+)-CC-1065 as a probe for intrinsic and protein-induced bending of DNA. J. Mol. Recognit. 7, 123.
161. Boger, D. L., and Johnson, D. S. (1996) CC-1065 and the duocarmycins: Understanding their biological function through mechanistic studies. Angew. Chem., Int. Ed. Engl. 35, 1438.
162. Krowicki, K., Balzarini, J., De Clercq, E., Newman, R. A., and Lown, J. W. (1988) Novel DNA groove binding alkylators: design, synthesis, and biological evaluation. J. Med. Chem. 31, 341.
163. Arcamone, F. A., Animati, F., Barbieri, B., Configliacchi, E., D'Alesio, R., Geroni, C., Giulani, F. C., Lazzari, E., Menozzi, M., Mongelli, N., Penco, S., and Verini, M. A. (1989) Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives. J. Med. Chem. 32, 774.
164. Baker, B. F., and Dervan, P. B. (1985) Sequence-specific cleavage of double-helical DNA. N-bromoacetyldistamycin. J. Am. Chem. Soc. 107, 8266.
165. Baker, B. F., and Dervan, P. B. (1989) Sequence-specific cleavage of DNA by N-bromoacetyldistamycin. Product and kinetic analyses. J. Am. Chem. Soc. 111, 2700.
166. Lee, M., Rhodes, A. L., Wyatt, M. D., Forrow, S., and Hartley, J. A. (1993) Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents. Anti-Cancer Drug Des. 8, 173.
167. Xie, G., Gupta, R., and Lown, J. W. (1995) Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues. Anti-Cancer Drug Des. 10, 389.
168. Wyatt, M. D., Lee, M., Garbirasd, B. J., Souhami, R. L., and Hartley, J. A. (1995) Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: Evidence for increased cytotoxicity with enhanced sequence specificity. Biochemistry 34, 13034.
169. Wyatt, M. D., Garbiras, B. J., Haskell, M. K., Lee, M., Souhami, R. L., and Hartley, J. A. (1994) Structure-activity relationship of a series of nitrogen-mustard- and pyrrole-containing minor groove-binding agents related to distamycin. Anti-Cancer Drug Des. 9, 511.
170. Wyatt, M. D., Lee, M., and Hartley, J. A. (1997) Alkylation specificity for a series of distamycin analogues that tether chlorambucil. Anti-Cancer Drug Des. 12, 49.
171. Ciucci, A., Manzini, S., Lombardi, P., and Arcamone, F. (1996) Backbone and benzoyl mustard carrying moiety modifies DNA interactions of distamycin analogues. Nucleic Acids Res. 24, 311.
172. Chen, H. Y., Liu, J. X., and Lown, J. W. (1995) Design, synthesis and evaluation of novel bismustard cross-linked lexitropsins. BioOrg. Med. Chem. Lett. 5, 2223.
173. Broggini, M., Erba, E., Ponti, M., Ballinari, D., Geroni, C., Spreafico, F., and D'Incalci, M. (1991) Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res. 51, 199.
174. Montecucco, A., Fontana, M., Focher, F., Lestingi, M., Spadari, S., and Ciarrochi, G. (1991) Specific inhibition of human DNA ligase adenylation by a distamycin derivative possessing antitumor activity. Nucleic Acids Res. 19, 1067.
175. Fontana, M., Lestingi, M., Mondello, C., Braghetti, A., Montecucco, A., and Ciarrochi, G. (1992) DNA binding properties of FCE24517, an electrophilic distamycin analogue. Anti-Cancer Drug Des. 7, 131.
176. Broggini, M., Coley, H. M., Mongelli, N., Pesenti, E., Wyatt, M. D., Hartley, J. A., and D'Incalci, M. (1995) DNA sequence-specific adenine alkylation by the novel drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acids Res. 23, 81.
177. Broggini, M., Moncollin, V., D'Incalci, M., Mongelli, N., and Mantovani, R. (1995) Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription. Nucleic Acids Res. 23, 1657.
178. Pezzoni, G., Grandi, M., Biasoli, G., Capolongo, L., Ballinari, D., Giuliani, F. C., Barbieri, B., Pastori, A., Pesenti, E., and Mongelli, N. (1991) Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamcyin A. Br. J. Cancer 64, 1047.
179. Coley, H. M., Mongelli, N., and D'Incalci, M. (1993) The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents. Biochem. Pharmacol. 45, 619.
180. Baraldi, P. G., Beria, I., Cacciari, B., Capolongo, L., Cozzi, P., Mongelli, N., Romagnoli, R., and Spalluto, G. (1996) Structure-activity relationship of novel tallimustine derivatives: synthesis and antitumor activity. BioOrg. Med. Chem. Lett. 6, 1247.
181. Brooks, N., Hartley, J. A., Simpson, J. E., Wright, S. R., Woo, S., Centioni, S., Fontaine, M. D., McIntyre, T. E., and Lee, M. (1997) Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies. BioOrg. Med. Chem. 5, 1497.
182. Rhoads, C. J. (1946) Nitrogen mustards in treatment of neoplatic disease. J. Am. Med. Assoc. 131, 656.
183. Wang, Y., Gupta, R., Huang, L., Luo, W., and Lown, J. W. (1996) Design, synthesis, cytotoxic properties and preliminary DNA sequencing evaluation of CPI-N-methylpyrrole hybrids. Enhancing effect of a trans double bond linker and role of the terminal amide functionality on cytotoxic potency. Anti-Cancer Drug Des. 11, 15.
184. 1H NMR and restrained molecular dynamics simulation. J. Am. Chem. Soc. 117, 8917.
185. Shishido, K., Haruna, S., Yamamura, C., Iitsuka, H., Nemoto, H., Shinohara, Y., and Shibuya, M. (1997) Synthesis and evaluation of the hybrid molecules possessing DNA-cleaving activity. BioOrg. Med. Chem. Lett. 7, 2617.
186. 32P-end-labeled DNA. Biochemistry 29, 6827.
187. Sigurdsson, S. T., Rink, S. M., and Hopkins, P. B. (1993) Affinity cross-linking of duplex DNA by a pyrrole-oligopeptide conjugate. J. Am. Chem. Soc. 115, 12633.
188. 2 containing an interstrand cross-link derived from a distamycin-pyrrole conjugate. Nucleic Acids Res. 24, 1566.
189. Walker, W. L., Kopka, M. L., Filipowsky, M. E., Dickerson, R. E., and Goodsell, D. S. (1995) Design of B-DNA cross-linking and sequence-reading molecules. Biopolymers 35, 543.
190. Gupta, R., Liu, J., Xie, G., and Lown, J. W. (1996) Novel DNA-directed alkylating agents consisting of naphthalimide, nitrogen mustard and lexitropsin moieties: synthesis, DNA sequence specificity and biological evaluation. Anti-Cancer Drug Des. 11, 581.
191. Nielsen, P. E. (1990) Chemical and photochemical probing of DNA complexes. J. Mol. Recognit. 3, 1.
192. Hartley, J. A., McAdam, S. R., Das, S., Roldan, M. C., Haskell, M. K., and Lee, M. (1994) Molecular and cellular pharmacology of novel photoactive psoralen and coumarin conjugates of pyrrole- and imidazole-containing analogues of netropsin. Anti-Cancer Drug Des. 9, 181.
193. Rao, K. E., Gosselin, G., Mrani, D., Périgaud, C., Imbach, J. L., Bailly, C., Hénichart, J. P., Colson, P., Houssier, C., and Lown, J. W. (1994) Psoralen-lexitropsin hybrids: DNA sequence selectivity of photoinduced cross-linking from MPE footprinting and exonuclease II stop assay, and mode of binding from electric linear dichroism. Anti-Cancer Drug Des. 9, 221.
194. Hartley, J. A., Webber, J., Wyatt, M. D., Bordenick, N., and Lee, M. (1995) Novel cytotoxic DNA sequence and minor groove targeted photosensitizers: Conjugates of pyrene and netropsin analogues. BioOrg. Med. Chem. Lett. 3, 623.
195. Herfeld, P., Helissey, P., and Giorgi-Renault, S. (1994) Poly(pyrrolecarboxamides) linked to photoactivable chromophore isoalloxazine. Synthesis, selective binding, and DNA cleaving properties. Bioconjugate Chem. 5, 67.
196. Bouziane, M., Ketterlé, C., Helissey, P., Herfeld, P., Le Bret, M., Giorgi-Renault, S., and Auclair, C. (1995) Sequence-directed single-strand cleavage of DNA by a netropsin-flavin hybrid molecule. Biochemistry 34, 14051.
197. Ketterlé, C., Gabarro-Arpa, J., Ouali, M., Bouziane, M., Auclair, C., Helissey, P., Giorgi-Renault, S., and Le Bret, M. (1996) Binding of Net-Fla, a netropsin-flavin hybrid molecule, to DNA: Molecular mechanics and dynamics studies in vacuo and in water solution. J. Biomol. Struct. Dyn. 13, 963.
198. Helissey, P., Bailly, C., Vishwakarma, J. N., Auclair, C., Waring, M. J., and Giorgi-Renault, S. (1996) DNA minor groove cleaving agents: synthesis, DNA binding and DNA cleaving properties of anthraquinone-oligopyrrolecarboxamide hybrids. Anti-Cancer Drug Des. 11, 527-551.
199. Meunier, B. (1992) Metalloporphyrins as versatile catalysts for oxidation reactions and oxidative DNA cleavage. Chem. Rev. 92, 141.
200. Anneheim-Herbelin, G., Perrée-Fauvet, M., Gaudemer, A., Helissey, P., and Giorgi-Renault, S. (1993) Porphyrin-netropsin: a potential ligand of DNA. Tetrahedron Lett. 34, 7263.
201. Perrée-Fauvet, M., and Gresh, N. (1994) Structure and energetics in the complexes of a double-stranded B-DNA dodecamer with netropsin derivatives of a tricationic water-soluble porphyrin: a theoretical investigation. J. Biomol. Struct. Dyn. 11, 1203.
202. Matsumoto, T., Utsumi, Y., Sakai, Y., Toyooka, K., and Shibuya, M. (1992) Synthesis of halogenated oligo-N-methylpyrrole-carboxamide derivatives and their photochemical DNA cleavage activities. Heterocycles 34, 1697.
203. Wilson, W. R. (1992) Tumour hypoxia: challenges for cancer chemotherapy. In The Search for New Anticancer Drugs (M. J. Waring and B. A. J. Ponder, Eds.) pp 87-131, Kluwer Academic Publishers, London.
204. Tocher, J. H., and Edwards, D. I. (1994) Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases. Biochem. Pharmacol. 48, 1089.
205. Kappen, L. S., Lee, T. R., Yang, C.-C., and Goldberg, I. H. (1989) Oxygen trasfer from the nitro group of a nitroaromatic radiosensitizer to a DNA sugar damage product. Biochemistry 28, 4540.
206. Nishiwaki, E., Lee, H., Matsumoto, T., Toyooka, K., Sakurai, H., and Shibuya, M. (1990) Synthesis of nitrated oligo-N-methylpyrrole carboxamide derivatives and their photochemical DNA cleaving properties. Tetrahedron Lett. 31, 1299.
207. Parrick, J., Porssa, M., Davies, L. K., Dennis, M. F., Patel, K. B., Stratford, M. R. L., and Wardman, P. (1993) Targeting radiosensitizers to DNA by minor groove binding: nitroarenes based on netropsin and distamycin. Bioorg. Med. Chem. Lett. 3, 1697.
208. Jenkins, T. C., Parrick, J., and Porssa, M. (1994) DNA-binding properties of nitroarene oligopeptides designed as hypoxia-selective agents. Anti-Cancer Drug Des. 9, 477.
209. Matsumoto, T., Sakai, Y., Toyooka, K., and Shibuya, M. (1992) Synthesis of sulfonamido oligo-N-methylpyrrole-carboxamide derivatives and their photochemical DNA cleavage activities. Heterocycles 33, 135.
210. Nishiwaki, E., Nakagawa, H., Takasaki, M., Matsumoto, T., Sakurai, H., and Shibuya, M. (1990) Synthesis of oligo-N-methylpyrrolecarboxamide derivatives and their photochemical DNA cleaving activities. Heterocycles 31, 1763.
211. Nishiwaki, E., Lee, H., Matsumoto, T., Toyooka, K., Sakurai, H., and Shibuya, M. (1990) Synthesis of nitrated oligo-N-methylpyrrole carboxamide derivatives and their photochemical DNA cleaving activities. Tetrahedron Lett 31, 1299.
212. Grokhovsky, S. L., and Zubarev, V. E. (1991) Sequence-specific cleavage of double-stranded DNA caused by X-ray ionization of the platinum atom in the Pt-bis-netropsin-DNA complex. Nucleic Acids Res. 19, 257.
213. Surovaya, A. N., Burckardt, G., Grokhovsky, S. L., Birch-Hirschfeld, E., Gursky, G. V., and Zimmer, C. (1997) Hairpin polyamides that use parallel and antiparallel side-by-side peptide motifs in binding to DNA. J. Biomol. Struct. Dyn. 14, 595.
214. Dabrowiak, J. C., Stankus, A. A., and Goodisman, J. (1992) Sequence-specificity of drug-DNA interactions. In Nucleic Acid Targeted Drug Design (C. L. Propst and T. J. Perun, Eds.) pp 93-149, Dekker, New York.
215. Bailly, C., and Waring, M. J. (1995) Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA. J. Biomol. Struct. Dyn. 12, 869.
216. Taylor, J. S., Schultz, P. G., and Dervan, P. B. (1984) DNA affinity cleaving. Sequence specific cleavage of DNA by distamycin-EDTA·Fe(II) and EDTA-distamycin·Fe(II). Tetrahedron 40, 457.
217. Schultz, P. G., and Dervan, P. B. (1983) Sequence-specific double-strand cleavage of DNA by penta-N-methylpyrrole-carboxamide-EDTA·Fe(II). Proc. Natl. Acad. Sci. U.S.A. 80, 6834.
218. Schultz, P. G., Taylor, J. S., and Dervan P. B. (1982) Design and synthesis of a sequence-specific DNA cleaving molecule. (distamycin-EDTA)iron(II). J. Am. Chem. Soc. 104, 6861.
219. II. J. Am. Chem. Soc. 105, 7748.
220. Youngquist, R. S., and Dervan, P. B. (1985) Sequence-specific recognition of B-DNA by bis(EDTA-distamycin)-fumaramide. J. Am. Chem. Soc. 107, 5528.
221. Youngquist, R. S., and Dervan, P. B. (1987) A synthetic peptide binds 16 base pairs of A,T double helical DNA. J. Am. Chem. Soc. 109, 7564.
222. Wade, W. S., Mrksich, M., and Dervan, P. B. (1992) Design of peptides that bind in the minor groove of DNA at 5′-(A,T)G(A,T)C(A,T)-3′ sequences by a dimeric side-by-side motif. J. Am. Chem. Soc. 114, 8783.
223. Mrksich, M., and Dervan, P. B. (1993) Antiparallel side-by-side heterodimer for sequence-specific recognition in the minor groove of DNA by distamycin/1-methylimidazole-2-carboxamide-netropsin pair. J. Am. Chem. Soc. 115, 2572.
224. Pickart, L., Freedman, J. H., Loker, W. J., Peisach, J., Perkins, C. M., Stenkamp, R. E., and Weinstein, B. (1980) Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature 288, 715.
225. Freedman, J. H., Pickart, L., Weinstein, B., Minis, W. B., and Peisach, J. (1982) Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry 21, 4540.
226. Chikira, M., Sato, T., Antholine, W. E., and Petering, D. H. (1991) Orientation of non-blue cupric complexes on DNA fibers. J. Biol. Chem. 266, 2859.
227. Sigman, D. S., Mazumder, A., and Perrin, D. M. (1993) Chemical nucleases. Chem. Rev. 93, 2295.
228. Bailly, C., Sun, J. S., Colson, P., Houssier, C., Hélène, C., Waring, M. J., and Hénichart, J. P. (1992) Design of a sequence-specific DNA-cleaving molecule which conjugates a copper-chelating peptide, a netropsin residue, and an acridine chromophore. Bioconjugate Chem. 3, 100.
229. Grokhovskii, S. L., Nikolaev, V. A., Zubarev, V. E., Surovaya, A. N., Zhuze, A. L., Chernov, B. K., Sidorova, N. Y., Zasedatelev, A. S., and Gurskii, G. V. (1993) Specific DNA cleavage by a netropsin analog containing a copper(II)-chelating peptide Gly-Gly-His. Mol. Biol. 6, 839.
230. Routier, S., Bernier, J. L., Catteau, J. P., and Bailly, C. (1997) Recognition and cleavage of DNA by a distamycin-salen·copper conjugate, BioOrg. Med. Chem. Lett. 7, 1729.
231. Stubbe, J., Kozarich, J. W., Wu, W., and Vanderwall, D. E. (1996) Bleomycins: a strucural model for specificity, binding, and double strand cleavage. Acc. Chem. Res. 29, 322.
232. Farinas, E., Tan, J. D., Baidya, N., and Mascharak, P. K. (1993) A designed synthetic analogue of Co(III)-bleomycin with enhanced DNA-binding and photocleaving activity. J. Am. Chem. Soc. 115, 2996.
233. Hénichart, J. P., Houssin, R., Bernier, J. L., and Catteau, J. P. (1982) Synthetic model of a bleomycin metal complex. J. Chem. Soc., Chem. Commun. 1295.
234. Hénichart, J. P., Bernier, J. L., Houssin, R., Lohez, M., Kénani, A., and Catteau, J. P. (1985) Copper(II)- and iron-(II)-complexes of methyl-2-(2-aminoethyl)-aminomethylpyridine-6-carboxyl-histidinate (AMPHIS), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR study. Biochem. Biophys. Res. Commun. 126, 1036.
235. Kohda, J., Shinozuka, K., and Sawai, H. (1995) A novel bleomycin model compound bearing hydrophilic steric factor exhibited high oxygen activating capacity. Tetrahedron Lett. 36, 5575.
236. Otsuka, M., Masuda, T., Haupt, A., Ohno, M., Shiraki, T., Sugiura, Y., and Maeda, K. (1990) Man-designed bleomycin with altered sequence specificity in DNA cleavage. J. Am. Chem. Soc. 112, 838.
237. Owa, T., Haupt, A., Otsuka, M., Kobayashi, S., Tomioka, N., Itai, A., Ohno, M., Shiraki, T., Uesugi, M., Sugiura, Y., and Maeda, K. (1992) Man-designed bleomycins: significance of the binding sites as enzyme models and the stereochemistry of the linker chain. Tetrahedron 48, 1193.
238. Huang, L., Morgan, R., and Lown, J. W. (1993) Design of DNA-cleaving molecules which incorporate a simplified metal-complexing moiety of bleomycin and lexitropsin carriers. Bioorg. Med. Chem. Lett. 3, 1751.
239. Huang, L., Quada, J. C., and Lown, J. W. (1994) Design and synthesis of DNA cleaving bleomycin models: 1,2-trans disubstituted cyclopropane units as novel linkers. Tetrahedron Lett. 35, 5323.
240. Huang, L., Quada, J. C., Jr., and Lown, J. W. (1995) Design, synthesis, and sequence selective DNA cleavage of functional models of bleomycins. 1. Hybrids incorporating a simple metal-complexing moiety of bleomycin and lexitropsin carriers. Bioconjugate Chem. 6, 21.
241. Huang, L., Quada, J. C., Jr., and Lown, J. W. (1995) Design, synthesis, and sequence selective DNA cleavage of functional models of bleomycins. II. 1,2-trans-disubstituted cyclopropane units as novel linkers. BioOrg. Med. Chem. 3, 647.
242. 2 by two-dimensional nuclear magnetic resonance methods and restrained molecular dynamics simulation. Bioconjugate Chem. 7, 670.
243. Kane, S. A., Natrajan, A., and Hecht, S. M. (1994) On the role of the bithiazole moiety in sequence-selective DNA cleavage by Fe·bleomycin. J. Biol. Chem. 269, 10899.
244. 2. A binding model based on NMR experiments and restrained molecular dynamics calculations. J. Am. Chem. Soc. 117, 7891.
245. 2: Evidence for intercalation using 2D NMR. J. Am. Chem. Soc. 116, 10843.
246. Nicolaou, K. C., Dai, W.-M., Tsay, S.-C., Estevez, V. A., and Wrasidlo, W. (1992) Designed enediynes: a new class of DNA-cleaving molecules with potent and selective anticancer activity. Science 256, 1172.
247. Nicolaou, K. C., Smith, A. L., and Yue, E. W. (1993) Chemistry and biology of natural and designed enedyines. Proc. Natl. Acad. Sci. U.S.A. 90, 5881.
248. Nicolaou, K. C., and Dai, W.-M. (1991) Chemistry and biology of the enedyine anticancer antibiotics. Angew. Chem., Int. Ed. Engl. 30, 1387
249. Tokuda, M., Fujiwara, K., Gomibuchi, T., Hirama, M., Uesugi, M., and Sugiura, Y. (1993) Synthesis of a hybrid molecule containing neocarzinostatin chromophore analogue and minor groove binder. Tetrahedron Lett. 34, 669.
250. Wittman, M. D., Kadow, J. F., Langley, D. R., Vyas, D. M., Rose, W. C., Solomon, W., and Zein, N. (1997) The synthesis and biological activity of enediyne minor groove binding hybrids. BioOrg. Med. Chem. Lett. 5, 1049.
251. Xie, Y., Miller, G. G., Cubitt, S. A., Soderlind, K.-J., Allalunis-Turner, M. J., and Lown, J. W. (1997) Enediynelexitropsin DNA-targeted anticancer agents. Physicochemical and cytotoxic properties in human neoplastic cells in vitro, and intracellular distribution. Anti-Cancer Drug Des. 12, 169.
252. Semmelhack, M. F., and Gallagher, J. J. (1994) The effect on DNA cleavage potency of tethering a simple cyclic enediyne to a netropsin analog. J. Org. Chem. 59, 4357.
253. Bregant, T. M., Groppe, J., and Little, R. D. (1994) New class of DNA-cleaving agents based on trimethylenemethane. J. Am. Chem. Soc. 116, 3635.
254. Spielmann, H. P., Fagan, P. A., Bregant, T. M., Little, R. D., and Wemmer, D. E. (1995) The binding modes of a rationally designed photoactivated DNA nuclease determined by NMR. Nucleic Acids Res. 23, 1576.
255. Xie, G., Morgan, A. R., and Lown, J. W. (1993) Synthesis and DNA cleaving properties of hybrid molecules containing propargylic sulfones and minor groove binding lexitropsins. Bioorg. Med. Chem. Lett. 3, 1565.
256. Flanagan, M. E., Rollins, S. B., and Williams, R. M. (1995) Netropsin and spermine conjugates of a water-soluble quinocarcin analog: analysis of sequence-specific DNA interactions. Chem. Biol. 2, 145.
257. Kamitori, S., and Takusagawa, F. (1992) Crystal strucutre of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. J. Mol. Biol. 225, 445.
258. 2-actinomycin D complexes and its host DNA. J. Am. Chem. Soc. 116, 4154.
259. Chen, H., Liu, X., and Patel, D. J. (1996) DNA bending and unwinding associated with actinomycin D antibiotics bound to partially overlapping sites on DNA. J. Mol. Biol. 258, 457.
260. Wang, A. H. J. (1992) Intercalate drug binding to DNA. Curr. Opin. Struct. Biol. 2, 361.
261. Chaires, J. B. (1990) Daunomycin binding to DNA: from the macroscopic to the microscopic. In Molecular Basis of Specificity in Nucleic Acid-Drug Interactions (B. Pullman and J. Jortner, Eds.) pp 225-245, Kluwer Academic Publishers, Dordrecht, The Netherlands.
262. Waring, M. J. (1993) Echinomycin and related quinoxaline antibiotics. In Molecular Aspects of Anticancer Drug-DNA Interactions (S. Neidle and M. J. Waring, Eds.) Vol. 1, pp 213-242, Macmillan, London.
263. Sugiura, Y., Shiraki, T., Konishi, M., and Oki, T. (1990) DNA intercalation and cleavage of an antitumor antibiotic dynemicin that contains anthracycline and enediyne cores. Proc. Natl. Acad. Sci. U.S.A. 87, 3831.
264. Lee, S. H., and Goldberg, I. H. (1989) Sequence-specific, strand-selective, and directional binding of neocarzinostatin chromophore to oligodeoxyribonucleotides. Biochemistry 28, 1019.
265. Bailly, C., and Hénichart, J. P. (1991) DNA recognition by intercalator-minor groove binder hybrid molecules. Bioconjugate Chem. 2, 379.
266. Bailly, C., and Hénichart, J. P. (1994) Molecular pharmacology of intercalator-minor groove binder hybrid groove binder hybrid molecules. In Molecular Aspects of Anticancer Drug-DNA Interactions (S. Neidle and M. J. Waring, Eds.) Vol. 2, pp 162-196, Macmillan, London.
267. Krivtsora, M. A., Moroshkina, E. B., and Glibin, E. (1984) DNA interaction with low molecular weight ligands with different structures. III. Complexes of DNA with distactins. Mol. Biol. 18, 950.
268. Boitte, N., Pommery, N., Colson, P., Houssier, C., Waring, M. J., Hénichart, J.-P., and Bailly, C. (1997) Synthesis, DNA-binding and cytotoxic properties of a bis(netropsin)-anthracenedione conjugate. Anti-Cancer Drug Des. 12, 481.
269. Eliadis, A., Phillips, D. R., Reiss, J. A., and Skorobogaty, A. (1988) The synthesis and DNA footprinting of acridine-linked netropsin and distamycin bifunctional mixed ligands. J. Chem. Soc., Chem. Commun. 1049.
270. Shinomiya, M., and Kuroda, R. (1992) Synthesis of novel DNA photocleaving agents with potent DNA cleaving activity. Tetrahedron Lett. 33, 2697.
271. Kuroda, R., Satoh, H., Shinomiya, M., Watanabe, T., and Otsuka, O. (1995) Novel DNA photocleaving agents with high DNA sequence sopecificity related to the antibiotic bleomycin A2. Nucleic Acids Res. 23, 1524.
272. Bailly, C., Pommery, N., Houssin, R., and Hénichart, J. P. (1989) Design, synthesis, DNA-binding and biological activity of a series of DNA minor groove binding intercalating drugs. J. Pharm. Sci. 78, 910.
273. Bailly, C., Helbecque, N., Hénichart, J. P., Colson, P., Houssier, C., Rao, K. E., Shea, R. G., and Lown, J. W. (1990) Molecular recognition between oligopeptides and nucleic acids. DNA sequence specificity and binding properties of an acridine-linked netropsin hybrid ligand. J. Mol. Recognit. 3, 26.
274. Fossé, P., René, B., Saucier, J. M., Hénichart, J. P., Waring, M. J., Colson, P., Houssier, C., and Bailly, C. (1994) Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding. Biochemistry 33, 9865.
275. Bailly, C., Collyn-d'Hooghe, M., Lantoine, D., Fournier, C., Hecquet, B., Fossé, P., Saucier, J. M., Colson, P., Houssier, C., and Hénichart, J. P. (1992) Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II. Biochem. Pharmacol. 43, 457.
276. René, B., Fossé, P., Khélifa, T., Jacquemin-Sablon, A., and Bailly, C. (1996) The 1′-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity. Mol. Pharmacol. 49, 343.
277. Bailly, C., OhUigin, C., Rivalle, C., Bisagni, E., Hénichart, J. P., and Waring, M. J. (1990) Sequence-selective binding of an ellipticine derivative to DNA. Nucleic Acids Res. 18, 6283.
278. Bourdouxhe, C., Colson, P., Houssier, C., Sun, J.-S., Montenay-Garestier, T., Hélène, C., Rivalle, C., Bisagni, E., Waring, M. J., Hénichart, J.-P., and Bailly, C. (1992) Binding of a distamycin-ellipticine hybrid molecule to DNA and chromatin: spectroscopic, biochemical and molecular modeling investigations. Biochemistry 31, 12385.
279. Bailly, C., Leclère, V., Pommery, N., Colson, P., Houssier, C., Rivalle, C., Bisagni, E., and Hénichart, J. P. (1993) Binding to DNA, cellular uptake and biological activity of a distamycin-ellipticine hybrid molecule. Anti-Cancer Drug Des. 8, 145.
280. Bailly, C., OhUigin, C., Houssin, R., Colson, P., Houssier, C., Rivalle, C., Bisagni, E., Hénichart, J. P., and Waring, M. J. (1992) DNA-binding properties of a distamycin-ellipticine hybrid molecule. Mol. Pharmacol. 41, 845.
281. Bailly, C., Michaux, C., Colson, P., Houssier, C., Sun, J. S., Garestier, T., Hélène, C., Hénichart, J. P., Rivalle, C., Bisagni, E., and Waring, M. J. (1994) Reaction of a biscationic distamycin-ellipticine hybrid ligand with DNA. Mode and sequence specificity of binding. Biochemistry 33, 15348.
282. Riou, J. F., Grondard, L., Naudin, A., and Bailly, C. (1995) Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II-mediated DNA cleavage: relation to cytotoxicity. Biochem. Pharmacol. 50, 424.
283. Mrani, D., Gosselin, G., Auclair, C., Balzarini, J., De Clercq, E., Paoletti, C., and Imbach, J. L. (1991) Synthesis, DNA binding and biological activity of oxazolopyridocarbazole-netropsin hybrid molecules. Eur. J. Med. Chem. 26, 481.
284. Subra, F., Carteau, S., Pager, J., Paoletti, J., Paoletti, C., Auclair, C., Mrani, D., Gosselin, G., and Imbach, J. L. (1991) Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotides. Biochemistry 30, 1642.
285. Subra, F., Mouscadet, J. F., Lavignon, M., Roy, C., and Auclair, C. (1993) Inhibition of the moloney murine leukemia virus cycle at a post reverse transcriptional step by the netropsin-intercalating hybrid molecule netropsin-oxazolopyridocarbazole. Biochem. Pharmacol. 45, 93.
286. Goulaouic, H., Carteau, S., Subra, F., Mouscadet, J. F., Auclair, C., and Sun, J.-S. (1994) Selective binding to polynucleotides of the hybrid intercalating groove binder bis-(pyrrolecarboxamide)-oxazolopyridocarbazole: a molecular modeling study. Biochemistry 33, 1412.
287. Plouvier, B., Houssin, R., Hecquet, B., Colson, P., Houssier, C., Waring, M. J., Hénichart, J. P., and Bailly, C. (1994) Antitumor combilexin. A thiazole-containing analogue of netropsin linked to an acridine chromophore. Bioconjugate Chem. 5, 475.
288. Denny, W. A., and Wakelin, L. P. G. (1986) Kinetic and equilibrium studies of the interaction of amsacrine and anilino ring-substituted analogues with DNA. Cancer Res. 46, 1717.
289. Bailly, C., Denny, W. A., Mellor, L., Wakelin, L. P. G., and Waring, M. J. (1992) Sequence-specificity of the binding of 9-aminoacridine- and amsacrine-4-carboxamides to DNA studied by DNase I footprinting. Biochemistry 31, 3514.
290. Bourdouxhe-Housiaux, C., Colson, P., Houssier, C., Waring, M. J., and Bailly, C. (1996) Interaction of DNA-threading netropsin-amsacrine combilexin with DNA and chromatin. Biochemistry 35, 4251.
291. Hénichart, J. P., Waring, M. J., Riou, J. F., Denny, W. A., and Bailly, C. (1997) Copper-dependent Oxidative and Topoisomerase II-mediated DNA Cleavage by a Netropsin-Amsacrine Combilexin. Mol. Pharmacol. 51, 448-461.
292. McCaunaughie, A. W., and Jenkins, T. C. (1995) Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity. J. Med. Chem. 38, 3488.
293. Gupta, R., Al-Said, N. H., Oreski, B., and Lown, J. W. (1996) Design, synthesis and to poisomerase II inhibition activity of 4′-demethylepipodophyllotoxin-lexitropsin conjugates. Anti-Cancer Drug Des. 11, 325.
294. Zhao, R., Oreski, B., and Lown, J. W. (1996) Synthesis and biological evaluation of hybrid molecules containing the pyrroloquinoline nucleus and DNA-minor groove binders. BioOrg. Med. Chem. Lett. 6, 2169.
295. Lown, J. W. (1995) Design and development of sequence selective lexitropsin DNA minor groove binders. Drug Dev. Res. 34, 145.
296. Geierstanger, B. H., and Wemmer, D. E. (1995) Complexes of the minor groove of DNA. Annu. Rev. Biophys. Biomol. Struct. 24, 463.
297. Zunino, F., Animati, F., and Capranico, G. (1995) DNA minor groove binding drugs. Curr. Pharm. Des. 1, 83.
298. Kahne, D. (1995) Strategies for the design of minor groove binders: a re-evaluation based on the emergence of site-selective carbohydrate binders. Chem. Biol. 2, 7.
299. Remy, J.-S., Sirlin, C., Vierling, P., and Behr, J.-P. (1994) Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjugate Chem. 5, 647.
300. Clanton, D. J., Buckeit, R. W., Jr, Terpening, S. J., Kiser, R., Mongelli, N., Borgia, N. L., Schultz, R., Narayanan, V., Bader, J. P., and Rice, W. G. (1995) Novel sulfonated and phosphonated analogues of distamycin which inhibit the replication of HIV. Antiviral Res. 27, 335.